 | Up a level |
Puspita, Rina and Hestiantoro, Andon and Agustina, Rina and Handayani, Nining and Sirait, Batara I. and Polim, Arie Adrianus and Asmarinah, Asmarinah (2024) Associations of HSD17B1 Gene Expression with its DNA Methylation and Estradiol Level in Polycystic Ovary Syndrome Indonesian Patients. OnLine Journal of Biological Sciences, 24 (2). pp. 154-169. ISSN 2410-8561
Puspita, Rina and Hestiantoro, Andon and Agustina, Rina and Handayani, Nining and Sirait, Batara I. and Polim, Arie Adrianus and Asmarinah, Asmarinah (2024) Associations of HSD17B1 Gene Expression with its DNA Methylation and Estradiol Level in Polycystic Ovary Syndrome Indonesian Patients. OnLine Journal of Biological Sciences, 24 (2). pp. 154-169. ISSN 2410-8561
Kristiani, Erna and Syahruddin, Elisna and Asmarinah, Asmarinah and Rachmadi, Lisnawati and Ham, Maria Fransisca and Zaini, Jamal and Kekalih, Aria and Heriyanto, Didik Setyo and Hidajat, Heriawaty and Gultom, Fajar Lamhot (2024) WNT/β-Catenin signaling pathway and clinicopathological factors in advanced stage non-small cell lung cancer: a multicenter study. Bali Medical Journal (Bali MedJ), 14 (1). pp. 115-121. ISSN 2302-2914
Harahap, Agnes Stephanie and Subekti, Imam and Panigoro, Sonar Soni and Asmarinah, Asmarinah and Lisnawati, Lisnawati and Werdhani, Retno Asti and Agustina, Hasrayati and Khoirunnisa, Dina and Mutmainnah, Mutiah and Gultom, Fajar Lamhot and Assadyk, Abdillah Hasbi and Ham, Maria Francisca (2023) Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression. Biomedicines, 11 (10). pp. 1-16. ISSN 2227-9059
Hamid, Agus Rizal A. H. and Putra, Harun W. Kusuma and Sari, Ningrum Paramita and Diana, Putri and Sesari, Saras Serani and Novita, Eka and Gultom, Fajar Lamhot and Saraswati, Meilania and Tanurahardja, Budiana and Asmarinah, Asmarinah and Umbas, Rainy and Mochtar, Chaidir A. (2020) Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy. BMC urology, 20 (71). pp. 1-10.
